Tudor Investment Corp’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$235K Sell
102,867
-599,254
-85% -$1.9M ﹤0.01% 3285
2025
Q4
$2.81M Buy
702,121
+12,859
+2% +$71.5K 0.01% 1563
2025
Q3
$5.83M Buy
689,262
+438,095
+174% +$4.25M 0.01% 1089
2025
Q2
$2.83M Sell
251,167
-400,819
-61% -$3.68M 0.01% 1425
2025
Q1
$6.17M Buy
651,986
+325,726
+100% +$3.29M 0.02% 698
2024
Q4
$3.67M Buy
326,260
+160,769
+97% +$2.83M 0.01% 865
2024
Q3
$4.68M Sell
165,491
-249,713
-60% -$6.44M 0.02% 744
2024
Q2
$7.94M Sell
415,204
-6,215
-1% -$159K 0.04% 464
2024
Q1
$13.8M Buy
421,419
+312,106
+286% +$9.96M 0.09% 243
2023
Q4
$3.61M Buy
+109,313
New +$3.09M 0.03% 798
2023
Q2
Sell
-109,715
Closed -$3.56M 2575
2023
Q1
$3.56M Buy
+109,715
New +$3.47M 0.06% 516
2022
Q4
Sell
-41,235
Closed -$1.48M 2514
2022
Q3
$1.48M Buy
+41,235
New +$1.45M 0.03% 673
2021
Q4
Sell
-125,000
Closed -$3.88M 2585
2021
Q3
$3.88M Buy
+125,000
New +$3M 0.06% 370
2021
Q2
Sell
-16,869
Closed -$341K 1684
2021
Q1
$341K Sell
16,869
-45,817
-73% -$871K 0.01% 1266
2020
Q4
$1M Buy
+62,686
New +$829K 0.03% 698
2016
Q1
Sell
-15,200
Closed -$184K 1804
2015
Q4
$184K Hold
15,200
0.01% 1456
2015
Q3
$243K Sell
15,200
-32,019
-68% -$625K 0.01% 1225
2015
Q2
$921K Buy
+47,219
New +$880K 0.03% 462

Other funds holding EVH

Tudor Investment Corp's EVH Position: Q1 2026 in Review

Tudor Investment Corp reduced its Evolent Health (EVH) stake by 85% in Q1 2026, selling an estimated $1.9M and leaving 102,867 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #3285.

Tudor Investment Corp first reported a position in EVH in Q2 2015 and has held it in 18 quarters since. The position peaked at $13.8M in Q1 2024. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Tudor Investment Corp held 102,867 shares of Evolent Health worth $235K as of Q1 2026.
  • Tudor Investment Corp sold 599,254 Evolent Health shares in Q1 2026, an estimated $1.9M.
  • Evolent Health made up ﹤0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #3285 holding.
  • Tudor Investment Corp first reported a position in Evolent Health in Q2 2015 and has held it in 18 quarters since.
  • Tudor Investment Corp's Evolent Health position peaked at $13.8M in Q1 2024.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.